Atlas Trials

A Study to Evaluate Eli Lilly's Insulin Dosing Algorithm to Control Glycemia in Insulin-treated Adults With Type 2 Diabetes

Clinical trial NCT05514080 · COMPLETED

Trial details

NCT number
NCT05514080
Sponsor
McGill University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2019-12-06
Primary completion
2021-09-04
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.